News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
851,814 Results
Type
Article (86779)
Company Profile (704)
Press Release (764330)
Multimedia
Podcasts (141)
Webinars (19)
Section
Business (232785)
Career Advice (4132)
Deals (39751)
Drug Delivery (129)
Drug Development (91075)
Employer Resources (198)
FDA (18167)
Job Trends (17359)
News (396749)
Policy (39805)
Tag
Academia (3002)
Academic (2)
Accelerated approval (9)
Adcomms (32)
Allergies (105)
Alliances (56968)
ALS (115)
Alzheimer's disease (1547)
Antibody-drug conjugate (ADC) (186)
Approvals (18116)
Artificial intelligence (384)
Autoimmune disease (35)
Automation (18)
Bankruptcy (406)
Best Places to Work (12633)
BIOSECURE Act (22)
Biosimilars (127)
Biotechnology (481)
Bladder cancer (96)
Brain cancer (39)
Breast cancer (381)
Cancer (2986)
Cardiovascular disease (239)
Career advice (3540)
Career pathing (34)
CAR-T (201)
CDC (39)
Cell therapy (557)
Cervical cancer (24)
Clinical research (74149)
Collaboration (1071)
Company closure (3)
Compensation (662)
Complete response letters (30)
COVID-19 (2896)
CRISPR (64)
C-suite (325)
Cystic fibrosis (117)
Data (2942)
Decentralized trials (2)
Denatured (49)
Depression (67)
Diabetes (372)
Diagnostics (6969)
Digital health (26)
Diversity (9)
Diversity, equity & inclusion (49)
Drug discovery (172)
Drug pricing (149)
Drug shortages (35)
Duchenne muscular dystrophy (129)
Earnings (97434)
Editorial (48)
Employer branding (25)
Employer resources (169)
Events (131356)
Executive appointments (901)
FDA (19821)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (4)
Frontotemporal dementia (10)
Funding (985)
Gene editing (142)
Generative AI (37)
Gene therapy (424)
GLP-1 (921)
Government (5243)
Grass and pollen (6)
Guidances (180)
Healthcare (20915)
Huntington's disease (31)
IgA nephropathy (42)
Immunology and inflammation (174)
Immuno-oncology (9)
Indications (40)
Infectious disease (3078)
Inflammatory bowel disease (163)
Inflation Reduction Act (13)
Influenza (66)
Intellectual property (119)
Interviews (813)
IPO (17895)
IRA (55)
Job creations (5192)
Job search strategy (2863)
Kidney cancer (15)
Labor market (55)
Layoffs (584)
Leadership (26)
Legal (10131)
Liver cancer (84)
Lung cancer (422)
Lymphoma (206)
Machine learning (9)
Management (65)
Manufacturing (419)
MASH (93)
Medical device (14706)
Medtech (14711)
Mergers & acquisitions (22545)
Metabolic disorders (939)
Multiple sclerosis (103)
NASH (23)
Neurodegenerative disease (137)
Neuropsychiatric disorders (39)
Neuroscience (2270)
NextGen: Class of 2025 (7687)
Non-profit (5089)
Now hiring (48)
Obesity (483)
Opinion (288)
Ovarian cancer (100)
Pain (115)
Pancreatic cancer (119)
Parkinson's disease (197)
Partnered (25)
Patents (306)
Patient recruitment (155)
Peanut (55)
People (65647)
Pharmaceutical (143)
Pharmacy benefit managers (24)
Phase I (22892)
Phase II (32192)
Phase III (24241)
Pipeline (1624)
Policy (232)
Postmarket research (3552)
Preclinical (10335)
Press Release (72)
Prostate cancer (144)
Psychedelics (41)
Radiopharmaceuticals (277)
Rare diseases (503)
Real estate (7399)
Recruiting (76)
Regulatory (27062)
Reports (61)
Research institute (2664)
Resumes & cover letters (650)
Rett syndrome (9)
RNA editing (9)
RSV (54)
Schizophrenia (92)
Series A (165)
Series B (109)
Service/supplier (30)
Sickle cell disease (65)
Special edition (22)
Spinal muscular atrophy (167)
Sponsored (36)
Startups (4300)
State (2)
Stomach cancer (16)
Supply chain (81)
Tariffs (63)
The Weekly (90)
Vaccines (892)
Venture capital (54)
Weight loss (327)
Women's health (48)
Worklife (20)
Date
Today (157)
Last 7 days (593)
Last 30 days (2807)
Last 365 days (34194)
2025 (17353)
2024 (38139)
2023 (42568)
2022 (53928)
2021 (58724)
2020 (57666)
2019 (51338)
2018 (39124)
2017 (37191)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1272)
Alabama (70)
Alaska (7)
Arizona (280)
Arkansas (14)
Asia (50471)
Australia (8873)
California (7600)
Canada (2333)
China (704)
Colorado (329)
Connecticut (342)
Delaware (200)
Europe (115791)
Florida (1122)
Georgia (259)
Hawaii (2)
Idaho (66)
Illinois (726)
India (32)
Indiana (382)
Iowa (18)
Japan (226)
Kansas (115)
Kentucky (32)
Louisiana (18)
Maine (73)
Maryland (1086)
Massachusetts (5818)
Michigan (273)
Minnesota (476)
Mississippi (3)
Missouri (98)
Montana (32)
Nebraska (26)
Nevada (80)
New Hampshire (73)
New Jersey (2126)
New Mexico (31)
New York (2143)
North Carolina (1223)
North Dakota (10)
Northern California (3271)
Ohio (245)
Oklahoma (16)
Oregon (48)
Pennsylvania (1628)
Puerto Rico (18)
Rhode Island (39)
South America (1654)
South Carolina (35)
South Dakota (1)
Southern California (2789)
Tennessee (126)
Texas (1153)
United States (28752)
Utah (225)
Virginia (207)
Washington D.C. (80)
Washington State (672)
West Virginia (4)
Wisconsin (83)
There are 851,814 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
HCW Biologics Regains Compliance with Nasdaq Capital Market Requirements
June 26, 2025
·
2 min read
Press Releases
ZyVersa Therapeutics Announces First Clinical Site Activation, Initiating Patient Recruitment for Cholesterol Efflux Mediator™ VAR 200’s Phase 2a Clinical Trial in Patients with Diabetic Kidney Disease (DKD)
June 26, 2025
·
6 min read
Press Releases
BridgeBio to Host Limb-girdle Muscular Dystrophy Type 2I/R9 Investor Webinar on Friday, July 11th at 8:00 am ET
June 26, 2025
·
2 min read
Press Releases
ProPhase Labs, Inc. Receives Additional 180 Day Extension from Nasdaq to Regain Compliance with Minimum Bid Price Rule
June 26, 2025
·
5 min read
Press Releases
Plus Therapeutics Provides Business Update on CNSide Diagnostics Subsidiary
June 26, 2025
·
12 min read
Press Releases
Protagonist Therapeutics to Host Conference Call to Announce an Oral Obesity Development Candidate
June 26, 2025
·
2 min read
Press Releases
Cellarity Initiates Phase 1 Clinical Study of CLY-124, a First-in-Class Globin-Switching Oral Medicine for the Treatment of Sickle Cell Disease
June 26, 2025
·
5 min read
Press Releases
Incyte Appoints Bill Meury Chief Executive Officer; Hervé Hoppenot to Retire
June 26, 2025
·
8 min read
Press Releases
Alto Neuroscience Identifies Biomarker and Reports Positive Pharmacodynamic Results from Exploratory Phase 2 Proof-of-Concept Trial of ALTO-203
June 26, 2025
·
8 min read
Press Releases
Intrinsic Therapeutics Announces the First Implantation of the Barricaid® Annular Closure Device via Endoscopic Approach
June 26, 2025
·
2 min read
1 of 85,182
Next
